Site icon Nexreg

Aug. 5 ā€“ US: Draft Guidance for Industry on Labeling OTC Skin Protectant Drug Products

An announcement from the FDA:

SUMMARY: The Food and Drug Administration (FDA) is announcing the availability of a draft guidance for industry entitled ā€œLabeling OTC Skin Protectant Drug Products.ā€ This guidance provides recommendations on how to label over-the-counter (OTC) skin protectant drug products. An OTC skin protectant active ingredient can be combined with another OTC skin protectant active ingredient or OTC external analgesic, first aid antiseptic, or sunscreen active ingredients. Each of these combinations has specific labeling requirements, and therefore labeling of OTC skin protectant drug products is complex. This guidance is designed to clarify the permitted combinations of active ingredients along with the corresponding required labeling.

DATES: Although you can comment on any guidance at any time (see 21 CFR 10.115(g)(5)), to ensure that the agency considers your comment on this draft guidance before it begins work on the final version of the guidance, submit written or electronic comments on the draft guidance by October 3, 2008.

Click on the link for more information.

Exit mobile version